Literature DB >> 28299651

Runx1 Structure and Function in Blood Cell Development.

Constanze Bonifer1, Elena Levantini2,3, Valerie Kouskoff4, Georges Lacaud5.   

Abstract

RUNX transcription factors belong to a highly conserved class of transcriptional regulators which play various roles in the development of the majority of metazoans. In this review we focus on the founding member of the family, RUNX1, and its role in the transcriptional control of blood cell development in mammals. We summarize data showing that RUNX1 functions both as activator and repressor within a chromatin environment, a feature that requires its interaction with multiple other transcription factors and co-factors. Furthermore, we outline how RUNX1 works together with other factors to reshape the epigenetic landscape and the three-dimensional structure of gene loci within the nucleus. Finally, we review how aberrant forms of RUNX1 deregulate blood cell development and cause hematopoietic malignancies.

Entities:  

Keywords:  Blood cell development; Chromatin structure; Isoforms; Leukaemia; RUNX1; Regulation of RUNX1 activity; Transcriptional networks

Mesh:

Substances:

Year:  2017        PMID: 28299651     DOI: 10.1007/978-981-10-3233-2_5

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  10 in total

1.  Pharmacological inhibition of aberrant transcription factor complexes in inversion 16 acute myeloid leukemia.

Authors:  Sandeep Potluri; Daniel Coleman; Constanze Bonifer
Journal:  Stem Cell Investig       Date:  2018-09-30

2.  Defective RAB1B-related megakaryocytic ER-to-Golgi transport in RUNX1 haplodeficiency: impact on von Willebrand factor.

Authors:  Gauthami Jalagadugula; Lawrence E Goldfinger; Guangfen Mao; Michele P Lambert; A Koneti Rao
Journal:  Blood Adv       Date:  2018-04-10

3.  Runx1 and Runx3 drive progenitor to T-lineage transcriptome conversion in mouse T cell commitment via dynamic genomic site switching.

Authors:  Boyoung Shin; Hiroyuki Hosokawa; Maile Romero-Wolf; Wen Zhou; Kaori Masuhara; Victoria R Tobin; Ditsa Levanon; Yoram Groner; Ellen V Rothenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-26       Impact factor: 12.779

4.  Diagnosis, prognosis and bioinformatics analysis of lncRNAs in hepatocellular carcinoma.

Authors:  Meiyu Dai; Siyuan Chen; Xiaomou Wei; Xuan Zhu; Fang Lan; Shengming Dai; Xue Qin
Journal:  Oncotarget       Date:  2017-09-28

5.  Regulation of RUNX1 dosage is crucial for efficient blood formation from hemogenic endothelium.

Authors:  Michael Lie-A-Ling; Elli Marinopoulou; Andrew J Lilly; Mairi Challinor; Rahima Patel; Christophe Lancrin; Valerie Kouskoff; Georges Lacaud
Journal:  Development       Date:  2018-03-12       Impact factor: 6.868

6.  Interplay between transcription regulators RUNX1 and FUBP1 activates an enhancer of the oncogene c-KIT and amplifies cell proliferation.

Authors:  Lydie Debaize; Hélène Jakobczyk; Stéphane Avner; Jérémie Gaudichon; Anne-Gaëlle Rio; Aurélien A Sérandour; Lena Dorsheimer; Frédéric Chalmel; Jason S Carroll; Martin Zörnig; Michael A Rieger; Olivier Delalande; Gilles Salbert; Marie-Dominique Galibert; Virginie Gandemer; Marie-Bérengère Troadec
Journal:  Nucleic Acids Res       Date:  2018-11-30       Impact factor: 16.971

7.  Intrachromosomal Amplification of Chromosome 21 in Childhood Acute Lymphoblastic Leukemia: Study of 3 Cases.

Authors:  Aleksandra Mroczkowska; Monika Lejman
Journal:  Case Rep Oncol       Date:  2021-03-29

8.  Enhanced protein isoform characterization through long-read proteogenomics.

Authors:  Rachel M Miller; Ben T Jordan; Madison M Mehlferber; Erin D Jeffery; Christina Chatzipantsiou; Simi Kaur; Robert J Millikin; Yunxiang Dai; Simone Tiberi; Peter J Castaldi; Michael R Shortreed; Chance John Luckey; Ana Conesa; Lloyd M Smith; Anne Deslattes Mays; Gloria M Sheynkman
Journal:  Genome Biol       Date:  2022-03-03       Impact factor: 13.583

9.  The Co-operation of RUNX1 with LDB1, CDK9 and BRD4 Drives Transcription Factor Complex Relocation During Haematopoietic Specification.

Authors:  Jane Gilmour; Salam A Assi; Laura Noailles; Monika Lichtinger; Nadine Obier; Constanze Bonifer
Journal:  Sci Rep       Date:  2018-07-10       Impact factor: 4.379

10.  Runt-related transcription factor 1 (Runx1) aggravates pathological cardiac hypertrophy by promoting p53 expression.

Authors:  Dianhong Zhang; Cui Liang; Pengcheng Li; Lulu Yang; Zhengyang Hao; Lingyao Kong; Xiaoxu Tian; Chenran Guo; Jianzeng Dong; Yanzhou Zhang; Binbin Du
Journal:  J Cell Mol Med       Date:  2021-06-30       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.